| Year |
Citation |
Score |
| 2024 |
Wolfe AR, Cui T, Baie S, Corrales-Guerrero S, Webb A, Castro-Aceituno V, Shyu DL, Karasinska JM, Topham JT, Renouf DJ, Schaeffer DF, Halloran M, Packard R, Robb R, Chen W, ... ... Williams TM, et al. Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions. Science Advances. 10: eadj3551. PMID 38427741 DOI: 10.1126/sciadv.adj3551 |
0.482 |
|
| 2020 |
Ramelow J, Brooks CD, Gao L, Almiman AA, Williams TM, Villalona-Calero MA, Duan W. The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models. Bmc Cancer. 20: 738. PMID 32770960 DOI: 10.1186/S12885-020-07212-6 |
0.366 |
|
| 2020 |
Merritt RE, Sebastian N, Williams TM. Surgery versus stereotactic body radiation therapy for early-stage non-small cell lung cancer: time to settle the debate. The Annals of Thoracic Surgery. PMID 32721455 DOI: 10.1016/J.Athoracsur.2020.05.151 |
0.312 |
|
| 2020 |
Sebastian NT, Miller ED, Yang X, Diaz DA, Tan Y, Dowell J, Spain J, Rikabi A, Elliott E, Knopp M, Williams TM. A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination with Transarterial Chemoembolization for Hepatocellular Carcinoma. International Journal of Radiation Oncology, Biology, Physics. PMID 32712254 DOI: 10.1016/J.Ijrobp.2020.07.033 |
0.303 |
|
| 2020 |
Qiu Z, Fa P, Liu T, Prasad CB, Ma S, Hong Z, Chan ER, Wang H, Li Z, He K, Wang QE, Williams TM, Yan C, Sizemore ST, Narla G, et al. A genome-wide pooled shRNA screen identifies PPP2R2A as a predictive biomarker for the response to ATR and CHK1 inhibitors. Cancer Research. PMID 32522823 DOI: 10.1158/0008-5472.Can-20-0057 |
0.325 |
|
| 2020 |
Boutrid H, Kassem M, Tozbikian G, Morgan E, White J, Shah M, Vandeusen J, Sardesai S, Williams N, Stover DG, Lustberg M, Wesolowski R, Pudavalli V, Williams TM, Konda B, et al. TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature. Frontiers in Endocrinology. 11: 228. PMID 32411090 DOI: 10.3389/Fendo.2020.00228 |
0.314 |
|
| 2020 |
Sebastian N, Merritt RE, Abdel-Rasoul M, Wu T, Bazan JG, Xu-Welliver M, Haglund K, D'Souza D, Kneuertz PJ, Williams TM. Recurrence after Stereotactic Body Radiation Therapy versus Lobectomy for Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. PMID 32353436 DOI: 10.1016/J.Athoracsur.2020.03.073 |
0.329 |
|
| 2020 |
Wu C, Williams TM, Robb R, Webb A, Wei L, Chen W, Mikhail S, Ciombor KK, Cardin DB, Timmers C, Krishna SG, Arnold M, Harzman A, Abdel-Misih S, Roychowdhury S, et al. Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32253228 DOI: 10.1158/1078-0432.Ccr-19-4193 |
0.305 |
|
| 2020 |
Sebastian NT, Tan Y, Miller ED, Williams TM, Diaz DA. Surgery with and without Adjuvant Radiotherapy are Associated with Similar Survival in T4 Colon Cancer. Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland. PMID 31910314 DOI: 10.1111/Codi.14953 |
0.313 |
|
| 2020 |
Ross HJ, Hu C, Higgins KA, Jabbour SK, Kozono DE, Owonikoko TK, Movsas B, Solberg T, Xiao C, Williams TM, Welsh JW, Simko J, Wang XF, Mohindra NA, Hsu C, et al. NRG Oncology/Alliance LU005: A phase II/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer. Journal of Clinical Oncology. 38: TPS9082-TPS9082. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps9082 |
0.328 |
|
| 2020 |
Ross HJ, Kozono DE, Urbanic JJ, Williams TM, Dufrane C, Bara I, Gandhi M, Schulze K, Brockman JM, Wang XF, Gao J, Vokes EE, Stinchcombe T. AFT-16: Phase II trial of atezolizumab before and after definitive chemoradiation (CRT) for unresectable stage III non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 38: 9045-9045. DOI: 10.1200/Jco.2020.38.15_Suppl.9045 |
0.322 |
|
| 2019 |
Williams TM. BRAF Inhibitor Radiosensitizes Thyroid Cancer-Response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 25: 6557. PMID 31676590 DOI: 10.1158/1078-0432.Ccr-19-2705 |
0.353 |
|
| 2019 |
Owen DH, Williams TM, Bertino EM, Mo X, Webb A, Schweitzer C, Liu T, Roychowdhury S, Timmers CD, Otterson GA. Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 134: 167-173. PMID 31319977 DOI: 10.1016/J.Lungcan.2019.06.017 |
0.345 |
|
| 2019 |
Sebastian N, Wu T, Driscoll E, Willers H, Kelly S, Musunuru HB, Mo X, Tan Y, Bazan J, Haglund K, Xu-Welliver M, Baschnagel AM, Ju A, Keane F, Williams TM. Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 140: 26-33. PMID 31176206 DOI: 10.1016/J.Radonc.2019.05.014 |
0.379 |
|
| 2019 |
Robb R, Yang L, Shen C, Wolfe A, Webb A, Zhang X, Vedaie M, Saji M, Jhiang SM, Ringel MD, Williams TM. Inhibiting BRAF Oncogene-Mediated Radioresistance Effectively Radiosensitizes BRAF Mutant Thyroid Cancer Cells by Constraining DNA Double-strand Break Repair. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31097454 DOI: 10.1158/1078-0432.Ccr-18-3625 |
0.32 |
|
| 2019 |
George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, et al. National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer. Cancer. PMID 31017664 DOI: 10.1002/Cncr.32150 |
0.33 |
|
| 2019 |
Sebastian N, Wu T, Bazan J, Driscoll E, Willers H, Yegya-Raman N, Bond L, Dwivedi A, Mo X, Tan Y, Xu-Welliver M, Haglund K, Jabbour SK, Keane FK, Williams TM. Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 134: 151-157. PMID 31005209 DOI: 10.1016/J.Radonc.2019.01.032 |
0.314 |
|
| 2019 |
Wolfe AR, Jain R, Pawlik TM, Walker J, Williams TM. Radiation-Induced Colitis in a Pancreatic Cancer Patient With a Germline BRCA2 Mutation: A Case Report. Advances in Radiation Oncology. 4: 10-14. PMID 30706003 DOI: 10.1016/J.Adro.2018.08.025 |
0.311 |
|
| 2019 |
Sebastian N, Miller ED, Williams TM, Noonan AM, Hays JL, Diaz Pardo DA. Association of liver-directed local therapy with overall survival in metastatic intrahepatic cholangiocarcinoma. Journal of Clinical Oncology. 37: e15659-e15659. DOI: 10.1200/Jco.2019.37.15_Suppl.E15659 |
0.312 |
|
| 2019 |
Wolfe AR, Robb R, Hegazi A, Shyu D, Abushahin L, Williams TM. Abstract B60: Optimization of biologic scheduling of gemcitabine and abraxane improves treatment response compared to the standard concurrent regimen in preclinical models of pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B60 |
0.338 |
|
| 2019 |
Wolfe A, Elliott E, Miller E, Williams B, Ayan A, Woollard J, Williams T, Pardo DAD. Bremsstrahlung SPECT Based Radiation Tumor Dosimetry Predicts for Tumor Control in Patients Treated with Yttrium-90 Radioembolization for Hepatic Metastases from Colorectal Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E176. DOI: 10.1016/J.Ijrobp.2019.06.2067 |
0.344 |
|
| 2019 |
Siedow M, Wolfe A, Nalin A, DiCostanzo D, Miller E, Pardo DAD, Williams T. Increasing Neutrophil to Lymphocyte Ratio Following Chemoradiation is a Poor Prognostic Factor and Directly Correlates with Splenic Dose for Borderline or Unresectable Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E245. DOI: 10.1016/J.Ijrobp.2019.06.1929 |
0.301 |
|
| 2018 |
Miller ED, Fisher JL, Haglund KE, Grecula JC, Xu-Welliver M, Bertino EM, He K, Shields PG, Carbone DP, Williams TM, Otterson GA, Bazan JG. Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database. Radiation Oncology (London, England). 13: 196. PMID 30290823 DOI: 10.1186/S13014-018-1142-7 |
0.307 |
|
| 2018 |
Sebastian NT, Xu-Welliver M, Williams TM. Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances. Journal of Thoracic Disease. 10: S2451-S2464. PMID 30206491 DOI: 10.21037/Jtd.2018.04.52 |
0.334 |
|
| 2018 |
Walston S, Salloum J, Grieco C, Wuthrick E, Diaz DA, Barney C, Manilchuk A, Schmidt C, Dillhoff M, Pawlik TM, Williams TM. Identifying Clinical Factors Which Predict for Early Failure Patterns Following Resection for Pancreatic Adenocarcinoma in Patients Who Received Adjuvant Chemotherapy Without Chemoradiation. American Journal of Clinical Oncology. PMID 29727311 DOI: 10.1097/Coc.0000000000000452 |
0.306 |
|
| 2018 |
Barney CL, Scoville N, Allan E, Ayan A, DiCostanzo D, Haglund KE, Grecula J, Williams T, Xu-Welliver M, Otterson GA, Bazan JG. Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis. International Journal of Radiation Oncology, Biology, Physics. 100: 748-755. PMID 29413286 DOI: 10.1016/J.Ijrobp.2017.11.025 |
0.308 |
|
| 2018 |
Welliver M, Mo X, Gunderson D, Dicostanzo D, Wald P, Bazan J, Williams T, Haglund K, Grecula J, Otterson G, Carbone D. P3.17-20 Impact of Significant Primary Tumor Size Reduction on Radiation Dose to Normal Structures in Patients Receiving Definitive Chemoradiotherapy Journal of Thoracic Oncology. 13: S1028. DOI: 10.1016/J.Jtho.2018.08.1976 |
0.308 |
|
| 2018 |
Wu T, Sebastian N, Mo X, Bazan J, Welliver M, Haglund K, Williams T. Pre-treatment Neutrophil to Lymphocyte ratio (NLR) is a Prognostic Biomarker for Overall Survival in Localized Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 102: e714. DOI: 10.1016/J.Ijrobp.2018.07.1917 |
0.342 |
|
| 2018 |
Sebastian N, Wu T, Mo X, Bazan J, Welliver M, Haglund K, Williams T. Three-Dimensional Maximum Tumor Diameter is Associated with Local and Distant Failure in Localized Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy (SBRT) International Journal of Radiation Oncology*Biology*Physics. 102: e705. DOI: 10.1016/J.Ijrobp.2018.07.1894 |
0.358 |
|
| 2018 |
Sebastian N, Wu T, Mo X, Bazan J, Welliver M, Haglund K, Williams T. Pre-treatment Serum Bicarbonate Predicts for Local Failure after Stereotactic Body Radiation Therapy (SBRT) in Patients with Localized Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e704. DOI: 10.1016/J.Ijrobp.2018.07.1892 |
0.32 |
|
| 2018 |
Fabian D, DiCostanzo D, Williams T, Welliver M, Bazan J, Barney C, Haglund K. Comparison of Acurosand Anisotropic Analytical Algorithm for dose calculation in the treatment of Early-Stage Non-Small Cell Lung Cancer Utilizing Stereotactic Body Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 102: e681. DOI: 10.1016/J.Ijrobp.2018.07.1838 |
0.306 |
|
| 2018 |
Miller E, Fisher J, Haglund K, Grecula J, Welliver M, Bertino E, He K, Shields P, Carbone D, Williams T, Otterson G, Bazan J. Racial/Ethnic Disparities in the Delivery of Curative Intent Therapy in Patients with Stage III Non-small Cell Lung Cancer Not Treated Surgically: An Analysis of the National Cancer Database International Journal of Radiation Oncology*Biology*Physics. 102: e410. DOI: 10.1016/J.Ijrobp.2018.07.1205 |
0.32 |
|
| 2017 |
Miller ED, Fisher JL, Haglund KE, Grecula JC, Xu-Welliver M, Bertino EM, He K, Shields PG, Carbone DP, Williams TM, Otterson GA, Bazan JG. The addition of chemotherapy to radiation therapy improves survival in elderly patients with stage III non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29326090 DOI: 10.1016/J.Jtho.2017.11.135 |
0.338 |
|
| 2017 |
Chatterjee M, Ben-Josef E, Robb R, Vedaie M, Seum S, Thirumoorthy K, Palanichamy K, Harbrecht M, Chakravarti A, Williams TM. Caveolae-Mediated Endocytosis is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy. Cancer Research. PMID 28923854 DOI: 10.1158/0008-5472.Can-17-0604 |
0.378 |
|
| 2017 |
Ratnam NM, Peterson JM, Talbert EE, Ladner KJ, Rajasekera PV, Schmidt CR, Dillhoff ME, Swanson BJ, Haverick E, Kladney RD, Williams TM, Leone GW, Wang DJ, Guttridge DC. NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development. The Journal of Clinical Investigation. PMID 28891811 DOI: 10.1172/Jci91561 |
0.345 |
|
| 2017 |
Wald P, Mo X, Barney C, Gunderson D, Haglund AK, Bazan J, Grecula J, Chakravarti A, Williams T, Carbone DP, Xu-Welliver M. Prognostic value of primary tumor volume changes on kV-CBCT during definitive chemoradiotherapy for stage III non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28843360 DOI: 10.1016/J.Jtho.2017.08.010 |
0.357 |
|
| 2017 |
Fogh SE, Deshmukh S, Berk LB, Dueck AC, Roof K, Yacoub S, Gergel T, Stephans K, Rimner A, DeNittis A, Pablo J, Rineer J, Williams TM, Bruner D. A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012. International Journal of Radiation Oncology, Biology, Physics. 97: 786-796. PMID 28244415 DOI: 10.1016/J.Ijrobp.2016.11.022 |
0.315 |
|
| 2017 |
Wu CS, Williams TM, Wei L, Umar H, Mikhail S, Ciombor KK, Noonan AM, Roychowdhury S, El-Dika SS, Krishna S, Upchurch B, McCarthy ST, Arnold M, Harzman A, Abdel-Misih S, et al. Phase I study of neoadjuvant 5-fluorouracil (5FU) chemoradiation (CRT) and trametinib in patients with locally advanced rectal cancers (LARC). Journal of Clinical Oncology. 35: 685-685. DOI: 10.1200/Jco.2017.35.4_Suppl.685 |
0.314 |
|
| 2017 |
Williams TM, Wu C, Wei L, Chan E, Robb R, Roychowdhury S, Webb A, Timmers C, Bekaii-Saab T, Wuthrick E. Abstract CT088: A phase I trial combining MEK-1/2 inhibition in combination with 5-fluorouracil and radiation for locally-advanced rectal adenocarcinoma Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Ct088 |
0.335 |
|
| 2017 |
Robb RN, Yang L, Williams T. Abstract 5186: Vemurafenib selectively radiosensitizes BRAF V600E mutant papillary and anaplastic thyroid carcinoma cells Cancer Research. 77: 5186-5186. DOI: 10.1158/1538-7445.Am2017-5186 |
0.352 |
|
| 2017 |
Wald P, Mo X, Barney C, Grecula J, Williams T, Haglund K, Bazan J, Welliver M. Tumor Volume Dynamics on kV-CBCT During Definitive Radiation Therapy for Locally Advanced NSCLC: Implications for Prognosis and Adaptive Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 99: E499-E500. DOI: 10.1016/J.Ijrobp.2017.06.1796 |
0.302 |
|
| 2017 |
Bazan J, Barney C, Grecula J, Haglund K, Welliver M, Williams T. The Impact of Planning Target Volume D95 in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non–small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E440-E441. DOI: 10.1016/J.Ijrobp.2017.06.1657 |
0.314 |
|
| 2017 |
Bazan J, Barney C, DiCostanzo D, Scoville N, Grecula J, Haglund K, Welliver M, Williams T, Ayan A. Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Treated With Concurrent Chemoradiation for Locally Advanced Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E440. DOI: 10.1016/J.Ijrobp.2017.06.1656 |
0.302 |
|
| 2016 |
Huang Z, Feng Y, Lo S, Williams T, Grecula J, Mayr N, Yuh W. SU-F-T-105: The Predicted Radiation Response of Non-Small Cell Lung Cancer for SRS, SBRT and HDR Brachytherapy. Medical Physics. 43: 3485-3486. PMID 28048006 DOI: 10.1118/1.4956241 |
0.309 |
|
| 2016 |
Bazan JG, Barney C, Scoville N, Haglund KE, Grecula JC, Welliver MX, Otterson G, Williams TM. Increased Posttreatment Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Marker for Worse Overall Survival in Patients Receiving Concurrent Chemoradiation for Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E479. PMID 27674801 DOI: 10.1016/J.Ijrobp.2016.06.1833 |
0.317 |
|
| 2016 |
Letham JO, Erdal BS, Mo X, Salamekh S, Ayan A, Williams TM, Haglund KE, Prevedello LM, Bazan JG, White RD, Welliver MX. Texture Features of Kilovolt Cone Beam CT (kvCBCT) During Stereotactic Body Radiation Therapy (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC) Highlight Differences Between Nonrecurrent and Recurrent Patients. International Journal of Radiation Oncology, Biology, Physics. 96: E435-E436. PMID 27674684 DOI: 10.1016/J.Ijrobp.2016.06.1724 |
0.307 |
|
| 2016 |
McMichael EL, Jaime-Ramirez AC, Guenterberg KD, Luedke E, Atwal LS, Campbell A, Hu Z, Tatum AS, Kodadasula SV, Mo X, Tridandapani S, Bloomston M, Ellison EC, Williams TM, Bekaii-Saab T, et al. IL-21 enhances natural killer cell response to cetuximab-coated pancreatic tumor cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27435400 DOI: 10.1158/1078-0432.Ccr-16-0004 |
0.341 |
|
| 2016 |
Salamekh S, Rong Y, Ayan AS, Mo X, Williams TM, Mayr NA, Grecula JC, Chakravarti A, Xu-Welliver M. Inter-Fraction Tumor Volume Response during Lung Stereotactic Body Radiation Therapy Correlated to Patient Variables. Plos One. 11: e0153245. PMID 27049962 DOI: 10.1371/Journal.Pone.0153245 |
0.324 |
|
| 2016 |
Patel AK, Pan XJ, Williams TM, Wuthrick EJ. The prognostic significance of perineural invasion in patients with esophageal adenocarcinoma treated with neoadjuvant chemoradiotherapy. Journal of Clinical Oncology. 34: 146-146. DOI: 10.1200/Jco.2016.34.4_Suppl.146 |
0.307 |
|
| 2016 |
Williams TM, Wuthrick E, Wu C, Robb R, Timmers C, Bekaii-Saab T. Abstract CT025: A phase I trial combining MEK-1/2 inhibition in combination with 5-fluorouracil and radiation for KRAS, BRAF, and NRAS mutant locally advanced rectal adenocarcinoma Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct025 |
0.336 |
|
| 2016 |
Williams TM, Chatterjee M, Robb R, Vedaie M, Seum S, Krishnan T, Kamalakanan P, Ben-Josef E, Chakravarti A. Abstract 405: Caveolin-1 expression mediates response to albumin-bound paclitaxel Cancer Research. 76: 405-405. DOI: 10.1158/1538-7445.Am2016-405 |
0.416 |
|
| 2016 |
Yang L, Kumar B, Li T, Romito M, Teknosa TN, Chakravarti A, Williams TM. Abstract 3045: The SMAC-Mimetic LCL161 exhibits strong synergy with radiation in vivo in head and neck squamous cell carcinoma by promoting tumor cell apoptosis Cancer Research. 76: 3045-3045. DOI: 10.1158/1538-7445.Am2016-3045 |
0.343 |
|
| 2015 |
Estrada-Bernal A, Chatterjee M, Haque SJ, Yang L, Morgan MA, Kotian S, Morrell D, Chakravarti A, Williams TM. MEK Inhibitor GSK1120212-Mediated Radiosensitization of Pancreatic Cancer Cells Involves Inhibition of DNA Double-Strand Break Repair Pathways. Cell Cycle (Georgetown, Tex.). 0. PMID 26505547 DOI: 10.1080/15384101.2015.1104437 |
0.345 |
|
| 2015 |
Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, et al. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26438117 DOI: 10.1200/Jco.2015.62.0138 |
0.314 |
|
| 2015 |
Rong Y, Bazan JG, Sekhon A, Haglund K, Xu-Welliver M, Williams T. Minimal Inter-Fractional Fiducial Migration during Image-Guided Lung Stereotactic Body Radiotherapy Using SuperLock Nitinol Coil Fiducial Markers. Plos One. 10: e0131945. PMID 26158847 DOI: 10.1371/Journal.Pone.0131945 |
0.305 |
|
| 2015 |
Bertino EM, Williams TM, Nana-Sinkam SP, Shilo K, Chatterjee M, Mo X, Rahmani M, Phillips GS, Villalona-Calero MA, Otterson GA. Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients. Clinical Lung Cancer. 16: 466-474.e4. PMID 26123189 DOI: 10.1016/J.Cllc.2015.05.004 |
0.34 |
|
| 2015 |
Chatterjee M, Ben-Josef E, Thomas DG, Morgan MA, Zalupski MM, Khan G, Andrew Robinson C, Griffith KA, Chen CS, Ludwig T, Bekaii-Saab T, Chakravarti A, Williams TM. Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer. Scientific Reports. 5: 10867. PMID 26065715 DOI: 10.1038/Srep10867 |
0.436 |
|
| 2015 |
Chablani PV, Nguyen P, Robinson CA, Pan XJ, Walston SA, Wuthrick EJ, Williams TM. Association of perineural invasion with outcomes after neodjuvant chemoradiation for locally advanced rectal adenocarcinoma. Journal of Clinical Oncology. 33: 750-750. DOI: 10.1200/Jco.2015.33.3_Suppl.750 |
0.319 |
|
| 2015 |
Robb RN, Yang L, Chatterjee M, Saji M, Ringel M, Chakravarti A, Williams T. Abstract C31: Vemurafenib selectively radiosensitizes BRAF V600E mutant papillary and anaplastic thyroid carcinoma cells in vitro Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C31 |
0.326 |
|
| 2015 |
Yang L, Kumar B, Romito M, Teknosa TN, Chakravarti A, Williams TM. Abstract C144: LCL161, a SMAC mimetic, induces preferential radiosensitization in human papillomavirus negative head and neck squamous cell carcinoma through induction of apoptosis Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C144 |
0.312 |
|
| 2015 |
Chatterjee M, Vedaie M, Robb R, Seum S, Estrada-Bernal A, Krishnan T, Kamalakanan P, Lin C, Chakravarti A, Williams TM. Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B8 |
0.413 |
|
| 2015 |
Bazan J, Allan E, Washington I, Majithia L, Grecula J, Haglund K, Welliver M, Williams T. Increased Pretreatment Neutrophil-to-Lymphocyte Ratios and Platelet-to-Lymphocyte Ratios are Independent Prognostic Markers for Worse Overall Survival in Patients Receiving Concurrent Chemoradiation for Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E440. DOI: 10.1016/J.Ijrobp.2015.07.1667 |
0.303 |
|
| 2015 |
Bazan J, Ferreri C, Majithia L, Washington I, Grecula J, Haglund K, Welliver M, Williams T. Pretreatment Complete Blood Count Parameters Are Prognostic Biomarkers for Overall Survival and Progression Free Survival in Patients Receiving Stereotactic Body Radiation Therapy for T1-T2 Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E439. DOI: 10.1016/J.Ijrobp.2015.07.1665 |
0.313 |
|
| 2015 |
Bazan J, Ferreri C, Washington I, Grecula J, Haglund K, Welliver M, Williams T. Pretreatment Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Are Prognostic for Survival in a Heavily Pretreated Group of Patients Receiving Stereotactic Body Radiation Therapy to the Lung for Recurrent and/or Metastatic Tumors International Journal of Radiation Oncology*Biology*Physics. 93: E437-E438. DOI: 10.1016/J.Ijrobp.2015.07.1661 |
0.333 |
|
| 2015 |
Ferreri C, Williams T, Ju A, Grecula J, Mayr N, Huang Z. Differences in Radiosensitivity Among Tumors Undergoing Stereotactic Body Radiation Therapy to the Lung: Application of gLQ Radiobiologic Modeling International Journal of Radiation Oncology*Biology*Physics. 93: E432-E433. DOI: 10.1016/J.Ijrobp.2015.07.1650 |
0.318 |
|
| 2014 |
Williams TM, Majithia L, Wang SJ, Thomas CR. Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer. Seminars in Radiation Oncology. 24: 94-104. PMID 24635866 DOI: 10.1016/J.Semradonc.2014.01.001 |
0.318 |
|
| 2014 |
Chatterjee M, Williams TM. Abstract 4702: Caveolin-1 confers a multi-modality therapy resistance phenotype in pancreatic cancer cells Cancer Research. 74: 4702-4702. DOI: 10.1158/1538-7445.Am2014-4702 |
0.416 |
|
| 2014 |
Williams TM, Majithia L, Wang SJ, Thomas CR. WITHDRAWN: Defining the Role of Adjuvant Therapy: Cholangiocarcinoma and Gallbladder Cancer Seminars in Arthroplasty. DOI: 10.1053/J.Sart.2014.01.014 |
0.317 |
|
| 2014 |
Williams T, Chatterjee M. Caveolin-1 Confers a Multimodality Therapy Resistance Phenotype in Pancreatic Cancer Cells International Journal of Radiation Oncology*Biology*Physics. 90: S367. DOI: 10.1016/J.Ijrobp.2014.05.1188 |
0.315 |
|
| 2013 |
Ru P, Williams TM, Chakravarti A, Guo D. Tumor metabolism of malignant gliomas. Cancers. 5: 1469-84. PMID 24217114 DOI: 10.3390/Cancers5041469 |
0.305 |
|
| 2013 |
Williams TM, Nyati S, Ross BD, Rehemtulla A. Molecular imaging of the ATM kinase activity. International Journal of Radiation Oncology, Biology, Physics. 86: 969-77. PMID 23726004 DOI: 10.1016/J.Ijrobp.2013.04.028 |
0.301 |
|
| 2013 |
Kim EJ, Ben-Josef E, Herman JM, Bekaii-Saab T, Dawson LA, Griffith KA, Francis IR, Greenson JK, Simeone DM, Lawrence TS, Laheru D, Wolfgang CL, Williams T, Bloomston M, Moore MJ, et al. A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer. 119: 2692-700. PMID 23720019 DOI: 10.1002/Cncr.28117 |
0.313 |
|
| 2013 |
Williams TM, Maier A. Role of stereotactic body radiation therapy and proton/carbon nuclei therapies. Cancer Journal (Sudbury, Mass.). 19: 272-81. PMID 23708074 DOI: 10.1097/Ppo.0B013E31829452A5 |
0.345 |
|
| 2013 |
Williams T, Galbán S, Li F, Heist K, Galbán C, Lawrence TS, Holland EC, Thomae T, Chenevert T, Rehemtulla A, Ross BD. Abstract 4433: DW-MR imaging as a predictive biomarker of radiosensitization of GBM through targeted inhibition of checkpoint kinases. Cancer Research. 73: 4433-4433. DOI: 10.1158/1538-7445.Am2013-4433 |
0.372 |
|
| 2013 |
Salamekh S, Rong Y, Diavolitsis V, Williams T, Mayr N, Ayan A, Welliver M. Interfraction Tumor Volume Changes During Lung Stereotactic Body Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 87: S68. DOI: 10.1016/J.Ijrobp.2013.06.177 |
0.315 |
|
| 2012 |
Galbán S, Lemasson B, Williams TM, Li F, Heist KA, Johnson TD, Leopold JS, Chenevert TL, Lawrence TS, Rehemtulla A, Mikkelsen T, Holland EC, Galbán CJ, Ross BD. DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma. Plos One. 7: e35857. PMID 22536446 DOI: 10.1371/Journal.Pone.0035857 |
0.363 |
|
| 2012 |
Williams TM, Flecha AR, Keller P, Ram A, Karnak D, Galbán S, Galbán CJ, Ross BD, Lawrence TS, Rehemtulla A, Sebolt-Leopold J. Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. Molecular Cancer Therapeutics. 11: 1193-202. PMID 22411900 DOI: 10.1158/1535-7163.Mct-12-0098 |
0.375 |
|
| 2012 |
Williams TM, Flecha A, Keller P, Ram A, Karnak D, Ross B, Lawrence T, Rehemtulla A, Sebolt-Leopold J. Abstract B43: Co-targeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B43 |
0.383 |
|
| 2012 |
Guiou M, Mayr NA, Kim EY, Williams T, Lo SS. Stereotactic body radiotherapy for adrenal metastases from lung cancer Journal of Radiation Oncology. 1: 155-163. DOI: 10.1007/S13566-012-0037-8 |
0.348 |
|
| 2011 |
Yao H, Zeng ZZ, Fay KS, Veine DM, Staszewski ED, Morgan M, Wilder-Romans K, Williams TM, Spalding AC, Ben-Josef E, Livant DL. Role of α(5)β(1) Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells. Translational Oncology. 4: 282-92. PMID 21966545 DOI: 10.1593/Tlo.11133 |
0.395 |
|
| 2011 |
Schinske KA, Nyati S, Khan AP, Williams TM, Johnson TD, Ross BD, Tomás RP, Rehemtulla A. A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB. Molecular Cancer Therapeutics. 10: 1807-17. PMID 21859840 DOI: 10.1158/1535-7163.Mct-11-0362 |
0.341 |
|
| 2011 |
Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP, Frank PG. Role of cholesterol in the development and progression of breast cancer. The American Journal of Pathology. 178: 402-12. PMID 21224077 DOI: 10.1016/J.Ajpath.2010.11.005 |
0.686 |
|
| 2011 |
Galbán S, Lemasson B, Williams TM, Li F, Heist K, Johnson TD, Rehemtulla A, Galban C, Ross BD. Abstract 5281: Gemcitabine is evaluated as an alternative treatment to temozolomide for high grade gliomas Cancer Research. 71: 5281-5281. DOI: 10.1158/1538-7445.Am2011-5281 |
0.39 |
|
| 2011 |
Williams TM, Flecha A, Ram AN, Keller PR, Galban S, Galban C, Ross BD, Rehemtulla A, Sebolt-Leopold JS. Abstract 5090: Targeted inhibition of MEK and AKT pathways in combination with radiation as a novel treatment paradigm in pancreatic cancer Cancer Research. 71: 5090-5090. DOI: 10.1158/1538-7445.Am2011-5090 |
0.388 |
|
| 2011 |
Schinske K, Nyati S, Williams T, Johnson T, Ross B, Tomás RP, Rehemtulla A. Abstract 2311: A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB Cancer Research. 71: 2311-2311. DOI: 10.1158/1538-7445.Am2011-2311 |
0.354 |
|
| 2008 |
Di Vizio D, Adam RM, Kim J, Kim R, Sotgia F, Williams T, Demichelis F, Solomon KR, Loda M, Rubin MA, Lisanti MP, Freeman MR. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. Cell Cycle (Georgetown, Tex.). 7: 2257-67. PMID 18635971 DOI: 10.4161/Cc.7.14.6475 |
0.527 |
|
| 2007 |
Di Vizio D, Sotgia F, Williams TM, Hassan GS, Capozza F, Frank PG, Pestell RG, Loda M, Freeman MR, Lisanti MP. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression. Cancer Biology & Therapy. 6: 1263-8. PMID 17786030 DOI: 10.4161/Cbt.6.8.4447 |
0.694 |
|
| 2007 |
Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen K, Hazan RB. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Research. 67: 3106-16. PMID 17409417 DOI: 10.1158/0008-5472.Can-06-3401 |
0.525 |
|
| 2006 |
Williams TM, Sotgia F, Lee H, Hassan G, Di Vizio D, Bonuccelli G, Capozza F, Mercier I, Rui H, Pestell RG, Lisanti MP. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. The American Journal of Pathology. 169: 1784-801. PMID 17071600 DOI: 10.2353/Ajpath.2006.060590 |
0.673 |
|
| 2006 |
Medina FA, de Almeida CJ, Dew E, Li J, Bonuccelli G, Williams TM, Cohen AW, Pestell RG, Frank PG, Tanowitz HB, Lisanti MP. Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection. Infection and Immunity. 74: 6665-74. PMID 16982844 DOI: 10.1128/Iai.00949-06 |
0.762 |
|
| 2006 |
Medina FA, Williams TM, Sotgia F, Tanowitz HB, Lisanti MP. A novel role for caveolin-1 in B lymphocyte function and the development of thymus-independent immune responses. Cell Cycle (Georgetown, Tex.). 5: 1865-71. PMID 16929183 DOI: 10.4161/Cc.5.16.3132 |
0.7 |
|
| 2006 |
Hassan GS, Williams TM, Frank PG, Lisanti MP. Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2393-401. PMID 16415072 DOI: 10.1152/Ajpheart.01161.2005 |
0.672 |
|
| 2006 |
Sotgia F, Williams TM, Schubert W, Medina F, Minetti C, Pestell RG, Lisanti MP. Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. The American Journal of Pathology. 168: 292-309. PMID 16400031 DOI: 10.2353/Ajpath.2006.050429 |
0.769 |
|
| 2005 |
Li J, Hassan GS, Williams TM, Minetti C, Pestell RG, Tanowitz HB, Frank PG, Sotgia F, Lisanti MP. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle (Georgetown, Tex.). 4: 1817-25. PMID 16294037 DOI: 10.4161/Cc.4.12.2199 |
0.691 |
|
| 2005 |
Sotgia F, Williams TM, Cohen AW, Minetti C, Pestell RG, Lisanti MP. Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling. Cell Cycle (Georgetown, Tex.). 4: 1808-16. PMID 16294019 DOI: 10.4161/Cc.4.12.2198 |
0.504 |
|
| 2005 |
Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, Pestell RG, Di Vizio D, Loda M, Lisanti MP. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. The Journal of Biological Chemistry. 280: 25134-45. PMID 15802273 DOI: 10.1074/Jbc.M501186200 |
0.772 |
|
| 2005 |
Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. American Journal of Physiology. Cell Physiology. 288: C494-506. PMID 15692148 DOI: 10.1152/Ajpcell.00458.2004 |
0.551 |
|
| 2005 |
Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DL, Jelicks LA, Scherer PE, Kim JK, Lisanti MP. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. American Journal of Physiology. Cell Physiology. 288: C1317-31. PMID 15689413 DOI: 10.1152/Ajpcell.00489.2004 |
0.72 |
|
| 2005 |
Bonuccelli G, Sotgia F, Frank PG, Williams TM, de Almeida CJ, Tanowitz HB, Scherer PE, Hotchkiss KA, Terman BI, Rollman B, Alileche A, Brojatsch J, Lisanti MP. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. American Journal of Physiology. Cell Physiology. 288: C1402-10. PMID 15689409 DOI: 10.1152/Ajpcell.00582.2004 |
0.682 |
|
| 2004 |
Williams TM, Lisanti MP. The Caveolin genes: from cell biology to medicine. Annals of Medicine. 36: 584-95. PMID 15768830 DOI: 10.1080/07853890410018899 |
0.502 |
|
| 2004 |
Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. The Journal of Biological Chemistry. 279: 51630-46. PMID 15355971 DOI: 10.1074/Jbc.M409214200 |
0.754 |
|
| 2004 |
Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, Brasaemle DL, Scherer PE, Lisanti MP. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes. 53: 1261-70. PMID 15111495 DOI: 10.2337/Diabetes.53.5.1261 |
0.764 |
|
| 2004 |
Williams TM, Lee H, Cheung MW, Cohen AW, Razani B, Iyengar P, Scherer PE, Pestell RG, Lisanti MP. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia. The Journal of Biological Chemistry. 279: 24745-56. PMID 15044451 DOI: 10.1074/Jbc.M402064200 |
0.753 |
|
| 2004 |
Williams TM, Lisanti MP. The caveolin proteins. Genome Biology. 5: 214. PMID 15003112 DOI: 10.1186/Gb-2004-5-3-214 |
0.476 |
|
| 2003 |
Park DS, Cohen AW, Frank PG, Razani B, Lee H, Williams TM, Chandra M, Shirani J, De Souza AP, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry. 42: 15124-31. PMID 14690422 DOI: 10.1021/Bi0356348 |
0.777 |
|
| 2003 |
Woodman SE, Ashton AW, Schubert W, Lee H, Williams TM, Medina FA, Wyckoff JB, Combs TP, Lisanti MP. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. The American Journal of Pathology. 162: 2059-68. PMID 12759260 DOI: 10.1016/S0002-9440(10)64337-4 |
0.767 |
|
| 2003 |
Capozza F, Williams TM, Schubert W, McClain S, Bouzahzah B, Sotgia F, Lisanti MP. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. The American Journal of Pathology. 162: 2029-39. PMID 12759258 DOI: 10.1016/S0002-9440(10)64335-0 |
0.771 |
|
| 2003 |
Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. American Journal of Physiology. Cell Physiology. 285: C222-35. PMID 12660144 DOI: 10.1152/Ajpcell.00006.2003 |
0.646 |
|
| 2003 |
Williams TM, Cheung MW, Park DS, Razani B, Cohen AW, Muller WJ, Di Vizio D, Chopra NG, Pestell RG, Lisanti MP. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Molecular Biology of the Cell. 14: 1027-42. PMID 12631721 DOI: 10.1091/Mbc.E02-08-0503 |
0.686 |
|
| 2003 |
Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, Pereira de Souza A, Kitsis RN, Russell RG, Weiss LM, Tang B, Jelicks LA, Factor SM, Shtutin V, Tanowitz HB, et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. American Journal of Physiology. Cell Physiology. 284: C457-74. PMID 12388077 DOI: 10.1152/Ajpcell.00380.2002 |
0.617 |
|
| Show low-probability matches. |